BioLife Solutions Market Cap 2006-2019 | BLFS
BioLife Solutions market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. BioLife Solutions market cap as of July 18, 2019 is $0.32B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.319B | $0.020B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $154.825B | 29.16 |
| Medtronic (MDT) | Ireland | $135.913B | 19.41 |
| Stryker (SYK) | United States | $78.520B | 28.02 |
| Boston Scientific (BSX) | United States | $59.297B | 28.43 |
| Baxter (BAX) | United States | $42.385B | 26.71 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $29.267B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.937B | 41.41 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.411B | 16.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.385B | 0.00 |
| Terumo (TRUMY) | Japan | $21.889B | 25.17 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.108B | 0.00 |
| ResMed (RMD) | United States | $17.890B | 34.18 |
| Canopy Growth (CGC) | Canada | $12.379B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $12.175B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.239B | 48.98 |
| Insulet (PODD) | United States | $7.299B | 531.83 |
| William Demant Holdings (WILYY) | Denmark | $7.263B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.083B | 21.47 |
| Aurora Cannabis (ACB) | Canada | $7.048B | 69.50 |
| Perrigo (PRGO) | Ireland | $6.991B | 11.82 |
| GN STORE NORD (GNNDY) | Denmark | $6.409B | 32.73 |
| Haemonetics (HAE) | United States | $6.299B | 51.41 |
| ICU Medical (ICUI) | United States | $5.103B | 30.45 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.007B | 0.00 |
| Neogen (NEOG) | United States | $3.388B | 55.09 |
| NuVasive (NUVA) | United States | $3.018B | 24.64 |
| Agios Pharmaceuticals (AGIO) | United States | $2.894B | 0.00 |
| Hutchison China MediTech (HCM) | China | $2.829B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.507B | 53.42 |
| Quidel (QDEL) | United States | $2.307B | 23.94 |
| Aphria (APHA) | $1.619B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.549B | 889.60 |
| Phibro Animal Health (PAHC) | United States | $1.229B | 18.42 |
| AtriCure (ATRC) | United States | $1.216B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.171B | 24.86 |
| NanoString Technologies (NSTG) | United States | $1.107B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $1.086B | 28.83 |
| PetIQ (PETQ) | United States | $1.002B | 24.33 |
| Quanterix (QTRX) | United States | $0.820B | 0.00 |
| Cerus (CERS) | United States | $0.773B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.761B | 21.35 |
| Omeros (OMER) | United States | $0.760B | 0.00 |
| MacroGenics (MGNX) | United States | $0.739B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.701B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.608B | 29.43 |
| Surmodics (SRDX) | United States | $0.538B | 78.24 |
| OraSure Technologies (OSUR) | United States | $0.525B | 24.17 |
| Meridian Bioscience (VIVO) | United States | $0.492B | 15.03 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.465B | 0.00 |
| Vapotherm (VAPO) | United States | $0.327B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.324B | 22.45 |
| Cytosorbents (CTSO) | United States | $0.246B | 0.00 |
| Zynex (ZYXI) | United States | $0.239B | 24.60 |
| Bovie Medical (APYX) | United States | $0.214B | 0.00 |
| Chimerix (CMRX) | United States | $0.186B | 0.00 |
| United Health Products (UEEC) | United States | $0.171B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.167B | 0.00 |
| Owens & Minor (OMI) | United States | $0.166B | 3.52 |
| Fonar (FONR) | United States | $0.139B | 7.32 |
| Female Health (VERU) | United States | $0.138B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.100B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 19.97 |
| InfuSystems Holdings (INFU) | United States | $0.088B | 0.00 |
| Surface Oncology (SURF) | United States | $0.079B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.069B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.056B | 19.25 |
| MRI INTERVENTNS (MRIC) | United States | $0.052B | 0.00 |
